| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. | Chief Patient Officer | Common Stock | 1.8K | $17.5K | $9.73 | 18 Jun 2025 | Direct |
| Provention Bio, Inc. | Chief Commercial Officer | Option to Purchase Common Stock | 0 | 27 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 18 Jun 2025 | 0 | $0 | 3 | Chief Patient Officer | 23 Jun 2025, 16:16 |
| PRVB | Provention Bio, Inc. | 27 Apr 2023 | 5 | $0 | 4 | Chief Commercial Officer | 27 Apr 2023, 18:00 |
| PRVB | Provention Bio, Inc. | 10 Feb 2023 | 1 | -$45K | 4 | Chief Commercial Officer | 14 Feb 2023, 18:16 |
| PRVB | Provention Bio, Inc. | 10 Jan 2023 | 1 | $0 | 4 | Chief Commercial Officer | 11 Jan 2023, 20:10 |
| PRVB | Provention Bio, Inc. | 08 Dec 2022 | 2 | $0 | 4 | Chief Commercial Officer | 09 Dec 2022, 19:31 |
| PRVB | Provention Bio, Inc. | 18 Jan 2022 | 1 | $0 | 4 | Chief Commercial Officer | 20 Jan 2022, 16:20 |
| PRVB | Provention Bio, Inc. | 12 May 2021 | 1 | $0 | 4 | Chief Commercial Officer | 14 May 2021, 19:39 |